Randomized Prospective Study Comparing 5% Imiquimod and Photodynamic Therapy for Actinic Cheilitis.
Phase of Trial: Phase IV
Latest Information Update: 17 May 2017
At a glance
- Drugs Imiquimod (Primary) ; Methyl aminolevulinate
- Indications Cheilitis
- Focus Therapeutic Use
- 28 Mar 2012 Planned end date changed from 1 Jan 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 28 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 31 May 2011 Planned End Date changed from 1 Dec 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.